Siemens Healthineers AG

SMMNY | OTC

Price Alert Chart Builder DCF Calculator

$24.24

+$0.45 (+1.89%)

Nov 2, 2026, 9:33 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

+1.89%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

49.7

+6.3 pts

Fundamentals Average

Market Sentiment Neutral

Moat Narrow

Sector Rank #284/1028 (Top 28%)

Full Analysis

Key Statistics

Market Data

Market Cap $27.07B

1D Range

24.24 24.25

52W Range

19.32 28.10

Valuation (TTM)

PE 10.32

PB 1.22

EV/EBITDA 7.95

Valuation (NTM)

Forward PE 8.77

Forward PEG 41.31

Price Target $0.00

Cash Flow

FCF Yield 9.3%

SBC Adj. FCF Yield 9.3%

SBC Impact N/A

Margins

Gross Margin 39.0%

Operating Margin 14.8%

FCF Margin 9.6%

Growth (CAGR)

Revenue 3Y | 5Y 2.3% | 6.8%

Dil EPS 3Y | 5Y 11.5% | 4.5%

FCF 3Y | 5Y 36.4% | -2.1%

Returns

ROA 4.8%

ROE 12.0%

ROIC 7.3%

Financial Health

Net Debt

€12.15B ($13.88B)

Current Ratio 1.16

Interest Coverage 8.45

Dividends

Div Yield 2.48%

Payout Ratio 30.0%

FCF Payout Ratio 50.5%

All Key Statistics

Loading financial charts...

Profile

Siemens Healthineers AG (SMMNY), operating through its various subsidiaries, is a global enterprise that provides a comprehensive suite of diagnostic and therapeutic medical products and services. The...

Sector Healthcare

Industry Medical - Devices

Employees 74,000

IPO Date May 14, 2018

Website www.siemens-healthineers.com

Fiscal Year n/a

Full Company Profile

Latest News

1 month ago · seekingalpha.com

Siemens Healthineers AG (SMMNY) Discusses Foreign Exchange and Tariff Impacts on Q4 Revenue and Earnings Prepared Remarks Transcript

1 month ago · businesswire.com

Sun Nuclear Announces Validated Adaptive QA Solution in Support of New Radiotherapy System, Accela, by Siemens Healthineers

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, today announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technical experts and clinical partners for interoperability with the company's new radiotherapy system, Accela. Unveiled at the annual ASTRO conference, Accela is the first software-driven delivery system engineered for NeoArc (Dynamic Modulated Arc Therapy, DMAT), a new treatment technique that accelerates how radia.

2 months ago · seekingalpha.com

Siemens Healthineers: Successful Investment, Updating For H2 2026

Siemens Healthineers remains a high-conviction BUY with a reiterated €48/share price target, reflecting strong Imaging and Precision Therapy segments. I exclude Chinese recovery from my base case; growth is now driven by ex-China Imaging and Varian, with diagnostics seen as structurally impaired. 3Q26 results confirmed robust order momentum (1.3x book-to-bill), and margin strength (19.1%), and EPS guidance raised to €2.45, though tariff refunds contributed.

3 months ago · seekingalpha.com

Siemens Healthineers AG (SMMNY) Q3 2026 Earnings Call Transcript

3 months ago · wsj.com

Siemens Healthineers Cuts Revenue Outlook on Diagnostics Weakness

The German supplier of medical equipment now expects fiscal-year revenue to grow by between 3.5% and 4.0% on a comparable basis, compared with 4.5% to 5% previously.

3 months ago · reuters.com

Siemens Healthineers cuts revenue forecast citing diagnostics weakness

Medical technology firm Siemens Healthineers cut its 2026 revenue growth forecast on Friday to ‌a range of 3.5% to 4.0%, as China's procurement policy weighs on its diagnostics business.

4 months ago · seekingalpha.com

Siemens Healthineers AG (SMMNY) Discusses Q3 Pre-Close Updates: Foreign Exchange and Tariff Impacts on Revenue and Earnings Prepared Remarks Transcript

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞